| Cheril M Bailey, CRNA | |
|
7012 Arbor Leaf Ln, Chattanooga, TN 37421-1969 | |
| (423) 544-8782 | |
| Not Available |
| Full Name | Cheril M Bailey |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 21 Years |
| Location | 7012 Arbor Leaf Ln, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427024363 | NPI | - | NPPES |
| 4345756 | Other | TN | BCBS OF TN |
| 3622492 | Medicaid | TN | |
| 4077070 | Other | TN | BCBS |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Everest Anesthesia Llc | 2961868559 | 15 |
| Anesthesia Dynamics Llc | 3779832530 | 363 |
| Progressive Anesthesia Llc | 7618148263 | 12 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Progressive Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215225560 PECOS PAC ID: 7618148263 Enrollment ID: O20110912000776 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Wgg Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578843280 PECOS PAC ID: 4981875325 Enrollment ID: O20110915000641 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Greater Atlanta Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285043158 PECOS PAC ID: 7315264645 Enrollment ID: O20150326000819 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Cspm Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982142865 PECOS PAC ID: 4688941107 Enrollment ID: O20170612000628 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200508002106 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Entity Name | Everest Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568158418 PECOS PAC ID: 2961868559 Enrollment ID: O20230524002431 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cheril M Bailey, CRNA 7012 Arbor Leaf Lane, Chattanooga, TN 37421-1969 Ph: (423) 544-8782 | Cheril M Bailey, CRNA 7012 Arbor Leaf Ln, Chattanooga, TN 37421-1969 Ph: (423) 544-8782 |
News Archive
Pharmacoeconomic methods rank low as a decision influencer on formulary changes, according to a new survey released today by the Society of Hospital Medicine and the American Society of Health-System Pharmacists. Respondents reported that only 13 percent of formulary system decisions made by Pharmacy and Therapeutics committees in hospitals is influenced by pharmacoeconomic methods.
Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic (OA) technology as a new tool to improve the process of diagnosing breast cancer, today announced results from two analyses of the company's European MAESTRO post-market surveillance study.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that its Boke brand Pai Du Qing Zhi Tablet, a prescription medicine aimed at achieving the balance of Yin Yang by regulating metabolism, in order to cleanse the blood and detoxify, dispose of hemorrhoids, fight obesity and lower hyperlipemia, will be commercially launched in the third quarter of 2010.
The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.
Young children who live in households with one or more unrelated adults are nearly 50 times as likely to die from an inflicted injury, usually being shaken or struck, as children living with two biologic parents, report researchers from the University of Missouri-Columbia and the University of Chicago in the November 2005 issue of the journal Pediatrics.
› Verified 3 days ago
Megan A Spears, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Mr. Edward Brian Hallock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Amy T. Garner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Eun Hyea Godbold, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Christina Michelle Robinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St Ste C235, Chattanooga, TN 37403 Phone: 423-602-8400 | |
Mrs. Julie D Baggett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Susan L Battles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E Third St, Chattanooga, TN 37403 Phone: 423-778-7608 Fax: 423-778-2360 |